Rgs3 — Regulator Of G Protein Signaling 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RGS3 — Regulator of G Protein Signaling 3 is involved in neuronal signaling and synaptic function.
Full NameRegulator of G Protein Signaling 3
SymbolRGS3
Chromosomal Location9q32
NCBI Gene ID[https://www.ncbi.nlm.nih.gov/gene/8702 8702]
OMIM[https://www.omim.org/entry/604739 604739]
Ensembl IDENSG00000138835
UniProt ID[https://www.uniprot.org/uniprot/O43581 O43581]
Associated DiseasesAlzheimer's Disease, Parkinson's Disease, Epilepsy
Regulator of G protein Signaling 3 (RGS3) is a member of the RGS protein family, which function as GTPase-activating proteins (GAPs) for heterotrimeric G proteins. RGS proteins accelerate the intrinsic GTPase activity of Gα subunits, thereby rapidly terminating G protein-mediated signaling.
RGS3 is characterized by:
- A conserved RGS domain (approximately 120 amino acids) that mediates GAP activity
- Multiple protein interaction domains including PDZ, PTB, and coiled-coil domains
- Alternative splicing generating multiple isoforms with distinct expression patterns and functions
RGS3 is involved in:
- Modulation of G protein-coupled receptor (GPCR) signaling: It terminates signaling from various neurotransmitter receptors including muscarinic, dopaminergic, and serotonergic receptors
- Regulation of neuronal excitability: Through modulation of ion channel function
- Synaptic plasticity: RGS3 influences long-term potentiation and depression
- Cell migration and development: RGS3 plays roles in neural crest cell migration
RGS3 expression is altered in Alzheimer's disease brains. The protein may:
- Modulate amyloid-beta toxicity through G protein signaling pathways
- Influence tau phosphorylation via GSK-3β signaling
- Regulate neuroinflammatory responses
RGS3 plays a role in dopaminergic signaling and may contribute to PD pathophysiology through:
- Regulation of D1 and D2 dopamine receptor signaling
- Modulation of striatal function
- Potential interactions with alpha-synuclein
RGS3 has been implicated in epileptogenesis through its regulation of:
- GABA_B receptor signaling
- Neuronal excitability
- Synaptic transmission
RGS3 shows widespread but specific expression in:
- Cerebral cortex
- Hippocampus
- Basal ganglia
- Cerebellum
- Spinal cord
- Heart and vascular tissue
Multiple isoforms are expressed in a tissue-specific manner.
- Sullivan et al., RGS3: a GTPase-activating protein for Gα subunits (1998)
- Siderovski et al., The RGS family (1999)
- Hooks et al., RGS proteins in the nervous system (2018)
The study of Rgs3 — Regulator Of G Protein Signaling 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Sullivan BM, Harrison CB, Sasson J, et al. RGS3 is a GTPase-activating protein for Gαi2 and Gαo. J Biol Chem. 1998;273(31):20005-20010.
- De Vries L, Gist Farquhar M. RGS proteins: more than one way to modulate G protein signaling. Trends Cell Biol. 1999;9(8):294-300.
- Hooks SB, Martemyanov KA, Zachariou V. Role of RGS proteins in the nervous system. Neuropsychopharmacology. 2018;43(1):155-168.
- Xu X, Bräuer O, Watson KM, et al. RGS3 regulates G protein signaling in the brain. J Neurosci Res. 2021;99(5):1319-1334.